Search Within

Ellen Marlese Basu

  1. "2012"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Neuroblastoma Service (5)
  2. Pediatrics, Department of (5)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (4)
  5. GSK Faculty (4)
  6. Neuro-Oncology Service (4)

More Groups

People
  1. Brian Kushner (4)
  2. Kim Kramer (4)
  3. Nai-Kong Cheung (4)
  4. Shakeel Modak (4)
  5. Stephen Roberts (3)
  6. Katharine Hsu (2)

More People

Years
  1. 2012 (5)
Publications
  1. Pediatric Blood and Cancer (2)
  2. International Journal of Radiation Oncology, Biology, Physics (1)
  3. Journal of Immunotherapy (1)
  4. Leukemia (1)
Publishers
  1. Wiley Periodicals, Inc (2)
  2. Elsevier Inc. (1)
  3. Lippincott Williams & Wilkins (1)
  4. Nature Publishing Group (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S.; Gallagher, M.; Hsu, K.
    Journal of Immunotherapy (2012)

    Fulltext@MSK | Save
  • Stereotactic body radiation therapy for palliation in relapsed neuroblastoma
    Meeting Abstract

    Dharmarajan, K. V.; Basu, E. M.; Cheung, N. V.; Kramer, K.; Kushner, B. H.; Modak, S.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma: Preliminary results
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Gallagher, M.; Hsu, K.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia
    Journal Article

    Mar, B. G.; Bullinger, L.; Basu, E.; Schlis, K.; Silverman, L. B.; DoĢˆhner, K.; Armstrong, S. A.
    Leukemia (2012)

    Fulltext@MSK | Save